Institute of Nanotechnology of Microelectronics of the Russian Academy of Sciences, 32A Leninsky Prospekt, Moscow 119334, Russia.
Municipal Clinical Hospital No. 15 named after O.M. Filatov, 23 Veshnyakovskaya St., Moscow 111539, Russia.
Sensors (Basel). 2024 Jun 6;24(11):3681. doi: 10.3390/s24113681.
Fabry disease is a lysosomal storage disorder caused by a significant decrease in the activity or absence of the enzyme α-galactosidase A. The diagnostics of Fabry disease during newborn screening are reasonable, due to the availability of enzyme replacement therapy. This paper presents an electrochemical method using complementary metal-oxide semiconductor (CMOS)-compatible ion-sensitive field effect transistors (ISFETs) with hafnium oxide-sensitive surfaces for the detection of α-galactosidase A activity in dried blood spot extracts. The capability of ISFETs to detect the reaction catalyzed by α-galactosidase A was demonstrated. The buffer composition was optimized to provide suitable conditions for both enzyme and ISFET performance. The use of ISFET structures as sensor elements allowed for the label-free detection of enzymatic reactions with melibiose, a natural substrate of α-galactosidase A, instead of a synthetic fluorogenic one. ISFET chips were packaged with printed circuit boards and microfluidic reaction chambers to enable long-term signal measurement using a custom device. The packaged sensors were demonstrated to discriminate between normal and inhibited GLA activity in dried blood spots extracts. The described method offers a promising solution for increasing the widespread distribution of newborn screening of Fabry disease.
法布里病是一种溶酶体贮积病,由α-半乳糖苷酶 A 的活性显著降低或缺失引起。由于可进行酶替代治疗,对新生儿进行法布里病筛查的诊断是合理的。本文提出了一种使用互补金属氧化物半导体(CMOS)兼容的离子敏感场效应晶体管(ISFET)和氧化铪敏感表面的电化学方法,用于检测干血斑提取物中的α-半乳糖苷酶 A 活性。ISFET 检测α-半乳糖苷酶 A 催化反应的能力得到了证明。优化了缓冲液组成,为酶和 ISFET 性能提供了合适的条件。使用 ISFET 结构作为传感器元件,可以使用天然的 α-半乳糖苷酶 A 底物蜜二糖而不是合成的荧光底物来进行无标记的酶反应检测。ISFET 芯片与印刷电路板和微流控反应室进行了封装,以使用定制设备进行长期信号测量。封装后的传感器能够区分干血斑提取物中正常和抑制的 GLA 活性。所描述的方法为增加法布里病新生儿筛查的广泛分布提供了一个有前途的解决方案。